Newsroom

Displaying 11–20 of 128

March 30, 2026

Patent Board Upholds Seer's Nano and Micro Particle Protein Enrichment Patent in a Challenge by Bruker Subsidiaries

February 26, 2026

Seer Adopts Limited Duration Tax Benefit Preservation Plan to Protect its Valuable Tax Assets

February 26, 2026

Seer Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Full Year 2026 Outlook

February 19, 2026

Leading Scientists Demonstrate How Seer’s Proteograph Product Suite Advances Cardiovascular and Neurodegenerative Research at US HUPO 2026

February 18, 2026

Seer to Participate in the TD Cowen 46th Annual Health Care Conference

February 5, 2026

Seer to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026

December 1, 2025

Nature Genetics Study Validates Seer’s Proteograph Platform as Essential for Turning Genetic Signals Into Reliable Drug Targets and Biomarkers

November 7, 2025

Seer and Collaborators Unveil Broad New Data Demonstrating the Translational Power of Deep Proteomics at HUPO 2025

November 6, 2025

Seer Reports Third Quarter 2025 Financial Results

October 29, 2025

Seer to Participate in Upcoming November Investor Conferences

Starting your proteomics research is effortless

Connect with an expert to discuss which path to the full proteome is right for you.

  1. Bring the Proteograph Product Suite in-house
  2. Run a project with
    Seer Technology
    Access Center
  3. Conduct a project with
    a Seer service provider
    or Center of Excellence